Evidence map›Paper›PMID 29765305›Full record

ArticleFrontiers in cellular neuroscience2018

Commentary: Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice.

Barbara J Morley, Paul Whiteaker, Ana B Elgoyhen

Abstract readComment
In one paragraph

Article in Frontiers in cellular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Drug Discovery Targeting Nicotinic Acetylcholine Receptors for Hearing Loss.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. α9-Containing Nicotinic Receptors in Cancer.Frontiers in cellular neuroscience · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Barbara J MorleyBoys Town National Research Hospital, Omaha, NE, United States.
Paul WhiteakerDivision of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United States.
Ana B ElgoyhenCONICET, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular Dr. Héctor N. Torres (INGEBI), Buenos Aires, Argentina.

Funding

Relevance of α-Conotoxin MII Sensitive Nicotinic Receptor Subtypes to Nicotine AddictionR01DA042749 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI WHITEAKER, PAUL · 2017 to 2021
$2.8M
NIDA NIH HHS R01 DA042749
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha10Alpha9antibodiesbrainimmunohistochemistry (IHC)mousenicotinic acetylcholine receptors (nAChR)

Identifiers

PMID29765305
PMCPMC5938352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.